Behçet's disease epidemiology and demographics: Difference between revisions

Jump to navigation Jump to search
Line 38: Line 38:


===Race===
===Race===
*Behcet disease usually affects individuals of the Turkish, Asian, and Middle Eastern populations. Middle Eastern and Asian individuals are less likely to develop [disease name].
*Behcet disease usually affects individuals of the Turkish, Asian, and Middle Eastern populations. Middle Eastern and Asian individuals are more likely to develop Behcet disease due to theincreased incidence of skin pathergy and HLA-B51 antigen.


===Gender===
===Gender===

Revision as of 19:25, 16 April 2018

Behçet's disease Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Behçet's disease from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Behçet's disease epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Behçet's disease epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Behçet's disease epidemiology and demographics

CDC on Behçet's disease epidemiology and demographics

Behçet's disease epidemiology and demographics in the news

Blogs on Behçet's disease epidemiology and demographics</smal

Directions to Hospitals Treating Behçet's disease

Risk calculators and risk factors for Behçet's disease epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Hamid Qazi, MD, BSc [2]

Overview

Epidemiology and Demographics

Behçet syndrome is more common (and often more severe) along the ancient silk road, which extends from eastern Asia to the Mediterranean [1]. It is most common in Turkey (80 to 370 cases per 100,000), while the prevalence ranges from 13.5 to 20 per 100,000 in Japan, Korea, China, Iran, and Saudi Arabia [1]. Prevalence in Paris, France in 2003 was 7.1 per 100,000, with rates of 2.4 per 100,000 in those of European ancestry, of 34.6 per 100,000 in those of North African ancestry, and of 17.5 per 100,000 in those of Asian ancestry [2,3]. Estimates of prevalence in the United States and Europe have ranged from 0.12 to 7.5 per 100,000. Analysis of residents of Olmsted County, Minnesota over a 45-year period identified a prevalence of 5.2 per 100,000 [4]. It is somewhat more common in men in the eastern Mediterranean area and in women in north European countries, and it typically affects young adults 20 to 40 years of age [1]. Immigrant and refugee populations from areas of high Behçet syndrome prevalence demonstrate increased risk of disease development [5].

Incidence

  • The incidence/prevalence of [disease name] is approximately [number range] per 100,000 individuals worldwide.
  • In [year], the incidence/prevalence of [disease name] was estimated to be [number range] cases per 100,000 individuals worldwide.

Prevalence

  • The prevalence of behcet disease is approximately 80 to 370 per 100,000 individuals in Turkey. [1]
  • The prevalence of behcet disease is approximately 13.5 to 20 per 100,000 individuals in Iran, Japan, Korea, China and Saudi Arabia. [1]
  • The prevalence of behcet disease is approximately 7.1 per 100,000 individuals in Paris, France.[2]
  •  The prevalence of behcet disease is approximately 2.4 per 100,000 individuals in European ancestry[2]
  •  The prevalence of behcet disease is approximately 34.6 per 100,000 individuals in North African ancestry[2]
  • The prevalence of behcet disease is approximately 17.5 per 100,000 individuals in Asian ancestry[2]
  • The prevalence of behcet disease is approximately 0.12 to 7.5 per 100,000 individuals in the United States. [3]
  • The incidence/prevalence of [disease name] is approximately [number range] per 100,000 individuals worldwide.
  • In [year], the incidence/prevalence of [disease name] was estimated to be [number range] cases per 100,000 individuals worldwide.
  • The prevalence of [disease/malignancy] is estimated to be [number] cases annually.

Case-fatality rate/Mortality rate

  • In [year], the incidence of [disease name] is approximately [number range] per 100,000 individuals with a case-fatality rate/mortality rate of [number range]%.
  • The case-fatality rate/mortality rate of [disease name] is approximately [number range].

Age

  • Patients of all age groups may develop [disease name].
  • The incidence of [disease name] increases with age; the median age at diagnosis is [#] years.
  • [Chronic disease name] is usually first diagnosed among [age group].
  • Behcet disease commonly affects young adults 20 to 40 years of age.[4]

Race

  • Behcet disease usually affects individuals of the Turkish, Asian, and Middle Eastern populations. Middle Eastern and Asian individuals are more likely to develop Behcet disease due to theincreased incidence of skin pathergy and HLA-B51 antigen.

Gender

  • Behcet disease is more common in men in Mediterranean area and more common in women in north European countries.
  • [Disease name] affects men and women equally.
  • [Gender 1] are more commonly affected by [disease name] than [gender 2]. The [gender 1] to [gender 2] ratio is approximately [number > 1] to 1.

Region

  • The majority of behcet disease cases are reported along the ancient silk road ( from eastern Asia to the Mediterranean)[1]
  • Behcet disease is most common in Trukey.
  • [Disease name] is a common/rare disease that tends to affect [patient population 1] and [patient population 2].

Developed Countries

Developing Countries

References

  1. 1.0 1.1 1.2 Sakane T, Takeno M, Suzuki N, Inaba G (October 1999). "Behçet's disease". N. Engl. J. Med. 341 (17): 1284–91. doi:10.1056/NEJM199910213411707. PMID 10528040.
  2. 2.0 2.1 2.2 2.3 Mahr A, Belarbi L, Wechsler B, Jeanneret D, Dhote R, Fain O, Lhote F, Ramanoelina J, Coste J, Guillevin L (December 2008). "Population-based prevalence study of Behçet's disease: differences by ethnic origin and low variation by age at immigration". Arthritis Rheum. 58 (12): 3951–9. doi:10.1002/art.24149. PMID 19035493.
  3. Calamia KT, Wilson FC, Icen M, Crowson CS, Gabriel SE, Kremers HM (May 2009). "Epidemiology and clinical characteristics of Behçet's disease in the US: a population-based study". Arthritis Rheum. 61 (5): 600–4. doi:10.1002/art.24423. PMC 3024036. PMID 19405011.
  4. Sakane T, Takeno M, Suzuki N, Inaba G (October 1999). "Behçet's disease". N. Engl. J. Med. 341 (17): 1284–91. doi:10.1056/NEJM199910213411707. PMID 10528040.

Template:WH Template:WS